Outset Medical: BML buys 228,334 shares on October 1
The 10% owner reported purchases through the fund, which directly owns the shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Outset Medical, Inc. reported that BML Investment Partners, L.P. purchased 228,334 shares on October 1, 2026, in multiple transactions at $2.90 to $3.85 per share, averaging $3.53. The fund purchased 16,575 shares on October 2, 2026, at an average $3.8758 per share.
BML Capital Management, LLC is the fund’s general partner. Leonard Braden Michael, a 10% owner and the general partner’s managing member, exercises investment and voting control over the shares but disclaims beneficial ownership except to the extent of his pecuniary interest.
Insights
Analyzing...
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock F3, F1 | 16,575 | $3.8758 | $64K |
| Purchase | Common Stock F2, F1 | 228,334 | $3.53 | $806K |
Footnotes (3)
- F1. BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
- F2. The shares were purchased in multiple transactions between $2.90 and $3.85 with an average price of $3.53.
- F3. The shares were purchased in multiple transactions at an average price of $3.8758 per share.
Key Figures
Key Terms
beneficially owned regulatory
pecuniary interest regulatory
general partner financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.